Publications

Comparative Study
Journal Article Research Support, Non-U.S. Gov't
Ppublish 130 citations
Electronic publication date
May 1, 2008

View on Pubmed.gov 18028321 | View on doi.org 10.1111/j.1478-...

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

Search for publications in this journal Liver Int - 28(3):393-401

  • Beom Kyung Kim

    Search for this expert
    1
  • Jun Yong Park

    Search for this expert
  • Do Young Kim

    Search for this expert
  • Ja Kyung Kim
  • Kyung Sik Kim

    Search for this expert
  • Jin Sub Choi

    Search for this expert
  • Byung Soo Moon

    Search for this expert
  • Kwang Hyub Han
  • Chae Yoon Chon

    Search for this expert
  • Young Myoung Moon

    Search for this expert
  • Sang Hoon Ahn

    Search for this expert

Abstract

BACKGROUND

Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence.

PATIENTS AND METHODS

We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100,000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100,000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100 000copies/ml). Serum DNA level, biochemical tests, alpha-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery.

RESULTS

There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9%; P=0.043). In multivariate analysis, sustained viraemia (P=0.041) increased recurrence independently.

CONCLUSIONS

Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.

References

No references provided.

Cited by 130 citations (total)

Journal Article

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.

Electronic publication date October 14, 2011

Search for publications in this journal Int J Hepatol

Liang-He Yu [...] Shu-Qun Cheng et al.

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of...

Journal Article

Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.

Electronic publication date January 19, 2017

Search for publications in this journal Hepatol Int

Takao Watanabe [...] Yoichi Hiasa et al.

BACKGROUND AND AIM

Entecavir is one of the most-used nucleoside analogues for the treatment of patients with chronic hepatitis B virus...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances